173 related articles for article (PubMed ID: 27529726)
1. Design, Synthesis, and Evaluation of a Neurokinin-1 Receptor-Targeted Near-IR Dye for Fluorescence-Guided Surgery of Neuroendocrine Cancers.
Kanduluru AK; Srinivasarao M; Low PS
Bioconjug Chem; 2016 Sep; 27(9):2157-65. PubMed ID: 27529726
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a cholecystokinin 2 receptor-targeted near-infrared dye for fluorescence-guided surgery of cancer.
Wayua C; Low PS
Mol Pharm; 2014 Feb; 11(2):468-76. PubMed ID: 24325469
[TBL] [Abstract][Full Text] [Related]
3. Development of a Ligand-Targeted Therapeutic Agent for Neurokinin-1 Receptor Expressing Cancers.
Kanduluru AK; Low PS
Mol Pharm; 2017 Nov; 14(11):3859-3865. PubMed ID: 28969417
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a Neurokinin-1 Receptor-Targeted Technetium-99m Conjugate for Neuroendocrine Cancer Imaging.
Kanduluru AK; Srinivasarao M; Wayua C; Low PS
Mol Imaging Biol; 2020 Apr; 22(2):377-383. PubMed ID: 31292915
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a Centyrin-Based Near-Infrared Probe for Fluorescence-Guided Surgery of Epidermal Growth Factor Receptor Positive Tumors.
Mahalingam SM; Dudkin VY; Goldberg S; Klein D; Yi F; Singhal S; O'Neil KT; Low PS
Bioconjug Chem; 2017 Nov; 28(11):2865-2873. PubMed ID: 28945346
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and Evaluation of a Novel
Zhang H; Kanduluru AK; Desai P; Ahad A; Carlin S; Tandon N; Weber WA; Low PS
Bioconjug Chem; 2018 Apr; 29(4):1319-1326. PubMed ID: 29466853
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Novel Tumor-Targeted Near-Infrared Probe for Fluorescence-Guided Surgery of Cancer.
Mahalingam SM; Kularatne SA; Myers CH; Gagare P; Norshi M; Liu X; Singhal S; Low PS
J Med Chem; 2018 Nov; 61(21):9637-9646. PubMed ID: 30296376
[TBL] [Abstract][Full Text] [Related]
8. Real-time near-infrared bioimaging of a receptor-targeted cytotoxic dendritic theranostic agent.
Wu J; Zhou Y; Li S; Qu D; Zhu WH; Tian H
Biomaterials; 2017 Mar; 120():1-10. PubMed ID: 28011190
[TBL] [Abstract][Full Text] [Related]
9. Development of a Novel Histone Deacetylase-Targeted Near-Infrared Probe for Hepatocellular Carcinoma Imaging and Fluorescence Image-Guided Surgery.
Tang C; Du Y; Liang Q; Cheng Z; Tian J
Mol Imaging Biol; 2020 Jun; 22(3):476-485. PubMed ID: 31228075
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of near-infrared fluorescent rhodamines via an S
Wang Q; Huang K; Cai S; Liu C; Jiao X; He S; Zhao L; Zeng X
Org Biomol Chem; 2018 Oct; 16(39):7163-7169. PubMed ID: 30246856
[TBL] [Abstract][Full Text] [Related]
11. Development of tumor-targeted near infrared probes for fluorescence guided surgery.
Kelderhouse LE; Chelvam V; Wayua C; Mahalingam S; Poh S; Kularatne SA; Low PS
Bioconjug Chem; 2013 Jun; 24(6):1075-80. PubMed ID: 23642154
[TBL] [Abstract][Full Text] [Related]
12. Activatable near-infrared fluorescent probe for in vivo imaging of fibroblast activation protein-alpha.
Li J; Chen K; Liu H; Cheng K; Yang M; Zhang J; Cheng JD; Zhang Y; Cheng Z
Bioconjug Chem; 2012 Aug; 23(8):1704-11. PubMed ID: 22812530
[TBL] [Abstract][Full Text] [Related]
13. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.
Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M
J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605
[TBL] [Abstract][Full Text] [Related]
14. Differential consequences of neurokinin receptor 1 and 2 antagonists in metastatic breast carcinoma cells; Effects independent of Substance P.
Nizam E; Erin N
Biomed Pharmacother; 2018 Dec; 108():263-270. PubMed ID: 30223097
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Novel Prostate-Specific Membrane Antigen-Targeted Near-Infrared Imaging Agent for Fluorescence-Guided Surgery of Prostate Cancer.
Kularatne SA; Thomas M; Myers CH; Gagare P; Kanduluru AK; Crian CJ; Cichocki BN
Clin Cancer Res; 2019 Jan; 25(1):177-187. PubMed ID: 30201762
[TBL] [Abstract][Full Text] [Related]
16. Roles of full-length and truncated neurokinin-1 receptors on tumor progression and distant metastasis in human breast cancer.
Zhou Y; Zhao L; Xiong T; Chen X; Zhang Y; Yu M; Yang J; Yao Z
Breast Cancer Res Treat; 2013 Jul; 140(1):49-61. PubMed ID: 23807418
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, Characterization, and Biomedical Applications of a Targeted Dual-Modal Near-Infrared-II Fluorescence and Photoacoustic Imaging Nanoprobe.
Cheng K; Chen H; Jenkins CH; Zhang G; Zhao W; Zhang Z; Han F; Fung J; Yang M; Jiang Y; Xing L; Cheng Z
ACS Nano; 2017 Dec; 11(12):12276-12291. PubMed ID: 29202225
[TBL] [Abstract][Full Text] [Related]
18. A constitutively active form of neurokinin 1 receptor and neurokinin 1 receptor-mediated apoptosis in glioblastomas.
Akazawa T; Kwatra SG; Goldsmith LE; Richardson MD; Cox EA; Sampson JH; Kwatra MM
J Neurochem; 2009 May; 109(4):1079-86. PubMed ID: 19519779
[TBL] [Abstract][Full Text] [Related]
19. Expression of substance P, neurokinin 1 receptor, Ki-67 and pyruvate kinase M2 in hormone receptor negative breast cancer and evaluation of impact on overall survival.
Al-Keilani MS; Bdeir R; Elstaty RI; Alqudah MA
BMC Cancer; 2023 Feb; 23(1):158. PubMed ID: 36797689
[TBL] [Abstract][Full Text] [Related]
20. Molecular Targeted NIR-II Probe for Image-Guided Brain Tumor Surgery.
Kurbegovic S; Juhl K; Chen H; Qu C; Ding B; Leth JM; Drzewiecki KT; Kjaer A; Cheng Z
Bioconjug Chem; 2018 Nov; 29(11):3833-3840. PubMed ID: 30296054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]